← Open Payments lookup

TINA GREGG: Open Payments

NPI 1649463050 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,126 in 62 payments from 14 companies in 2025. Trend: 2023 $1,273 · 2024 $5,481 · 2025 $12,126

Speaker / faculty: $5,805Travel & lodging: $2,715Food & beverage: $2,121Consulting: $1,485
CompanyPaymentsAmount
Madrigal Pharmaceuticals35$11,122
ABBVIE INC.3$255
Ipsen Biopharmaceuticals, Inc6$179
Janssen Biotech, Inc.2$148
Novo Nordisk Inc2$94
Phathom Pharmaceuticals, Inc.3$66
Fujifilm Healthcare Americas Corporation1$47
Takeda Pharmaceuticals U.S.A., Inc.2$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
Intercept Pharmaceuticals, Inc.2$36

Products named: REZDIFFRA, IQIRVO, TREMFYA, RINVOQ, Wegovy, VOQUEZNA, UTASWAKO AFP-L3, DUPIXENT.

Industry payments across MS — which companies pay providers there.